June 4, 2024 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
The Committee will discuss new drug application (NDA) 215455, for midomafetamine (MDMA), submitted by Lykos Therapeutics, …
source
The Committee will discuss new drug application (NDA) 215455, for midomafetamine (MDMA), submitted by Lykos Therapeutics, …
source
Prev Post
Recover your password.
A password will be e-mailed to you.